FolioLanternBeta
EVMNEvommune, Inc.

Arthur Kirsch

Director at Evommune, Inc., as of Jul 8, 2026Sold $1.7M of stock in the past 12 months: 100% with no plan disclosed. Bought $133K of stock in 1 open-market purchase.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
10K
shares held after the latest filing, Evommune, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
$133K
open-market purchases, past 12 months (1 trade)
2
companies filed for

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJun 2026: $1.7M no plan disclosed$1.7MJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Evommune, Inc. (EVMN)DirectorNov 7, 2025Jul 8, 2026
Liquidia Corp (LQDA)DirectorMar 26, 2021Jun 18, 2026

Also a director at

Liquidia Corp (LQDA)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.